Afuco™ Anti-Human CXCR3 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CXCR3 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-CXCR3 antibodies can be used to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-192CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CXCR3 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |